Skip to main content
. Author manuscript; available in PMC: 2018 Jan 1.
Published in final edited form as: Womens Health Issues. 2016 Nov 30;27(1):36–42. doi: 10.1016/j.whi.2016.10.007

Table 2.

Descriptive analyses and Effect Sizes for Primary and Secondary Outcomes (N = 98)

Baseline 3MPS
M SE M SE Cohen’s D 95% CI

USO 31.03 48.10 6.93 20.05 0.66 −4.48 – 5.79
Risk Intentions 44.33 13.85 51.38 7.01 −0.66 −2.18 – .87
SVAWS-E 31.62 1.54 4.28 1.05 2.16 0.26-4.07
SVAWS-P 27.44 1.75 2.01 0.90 1.91 −0.12-3.95
SVAWS-S 5.67 0.56 0.40 0.23 1.28 0.66-1.90
DTS 71.49 34.49 45.37 39.14 0.71 −4.43 – 5.85
AUDIT 3.65 5.58 2.13 3.79 0.32 −0.34 – 0.99
Drug Use1 56 57.1 24 27.3 7.80 2.14 – 28.42

Note. All analyses are significant at p < .05. 3-mo PS = 3-months post shelter; USO = Unprotected Sexual Occasions; AUDIT = Alcohol Use Disorder Identification Test; SVAWS-E = Severity of Violence Against Women Scale-Emotional Harm; SVAWS-P = Severity of Violence Against Women Scale-Physical Harm; SVAWS-S = Severity of Violence Against Women Scale-Sexual Harm; DTS = Davidson Trauma Scale; 3MPS = 3-months post shelter.

1

Due to the categorical nature of drug use, statistics are reported as the n, %, and Odds Ratio, further, due to missing data at follow-up n = 74.